Cavitation Versus Whole-Body Electromyostimulation on Infilamatory Markers in Centeral Obesity
Overview
- Phase
- Not Applicable
- Status
- Active, not recruiting
- Sponsor
- Cairo University
- Enrollment
- 60
- Locations
- 1
- Primary Endpoint
- Inflammatory Markers
Overview
Brief Summary
The purpose of this study is to compare the effects of ultrasound cavitation and whole-body electromyostimulation (WB-EMS) on inflammatory markers in individuals with central obesity.
Detailed Description
Sixty individuals with central obesity were recruited from private clinics. And underwent a screening process to determine their eligibility based on the inclusion and exclusion criteria. Eligible participants were informed about the study details, procedures, potential risks, and benefits before obtaining written informed consent
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Treatment
- Masking
- Double (Participant, Outcomes Assessor)
Eligibility Criteria
- Ages
- 18 Years to 50 Years (Adult)
- Sex
- All
- Accepts Healthy Volunteers
- Yes
Inclusion Criteria
- •Adults aged 18-50 years.
- •Individuals diagnosed with central obesity, defined as a waist circumference greater than 102 cm in men and 88 cm in women.
- •Participants with a stable body weight for at least three months prior to the study.
- •No engagement in regular physical activity or weight loss programs in the past six months.
- •Willingness to adhere to study protocols and attend all scheduled sessions.
Exclusion Criteria
- •Individuals with chronic diseases other than obesity-related conditions, such as cardiovascular disease, diabetes, or severe hypertension.
- •Pregnant or lactating women.
- •Individuals with implanted electronic devices (e.g., pacemakers).
- •Participants with dermatological conditions or skin infections in the treatment area.
- •Individuals undergoing medication that may affect fat metabolism or inflammatory markers.
Outcomes
Primary Outcomes
Inflammatory Markers
Time Frame: 3 Monthes
Measurement of changes in levels of Tumor Necrosis Factor-alpha (TNF-alpha), and Interleukin-6 (IL-6) using ELISA (Enzyme-Linked Immunosorbent Assay) kits.
Secondary Outcomes
- Waist Circumference(3 Monthes)
- Body Weight(3 Monthes)
- Body Mass Index (BMI)(3 Monthes)
Investigators
Hadeer Elsayed Abdelrazik Elsayed Ramadan
physical therapist
Cairo University